⌘K

Login Start Free

Home/Filings/4/0001627223-22-000017

4//SEC Filing

Newman Mark 4

Accession 0001627223-22-000017

CIK 0001627223other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 9:56 AM ET

Size

9.6 KB

Accession

0001627223-22-000017

Insider Transaction Report

Form 4

Period: 2022-03-01

SVP and CFO

Transactions

Tax Payment
Common Stock
2022-03-01$25.98/sh−1,253$32,553→ 156,623.057 total
Award
Common Stock
2022-03-01+19,630→ 176,253.057 total
Award
Stock Option (Right to Buy)
2022-03-01+206,268→ 206,268 total
Exercise: $25.98Exp: 2032-03-01→ Common Stock (206,268 underlying)

Holdings

Common Stock
(indirect: By Children)
2,480

Footnotes (4)

[F1]Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
[F2]Includes directly owned shares, restricted stock units and dividend equivalent units.
[F3]Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2023.
[F4]These options are scheduled to vest in three equal annual installments beginning on March 1, 2023.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Chemours Co

CIK 0001627223

Entity typeother

Related Parties

1

filerCIK 0001524597

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 9:56 AM ET
Size: 9.6 KB

View on SEC.gov